论文信息 - Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study - 字舞流文

Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study

D. Cooper | P. Phanuphak | S. Khoo | S. Emery | A. Clarke | J. Amin | R. Puls | C. Orrell | A. Owen | M. Boffito | D. Back | L. Dickinson | L. Else | M. Losso | D. Egan | D. Carey